Prognostic Value of Rb-82 PET Myocardial Perfusion Imaging
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01474577|
Recruitment Status : Completed
First Posted : November 18, 2011
Last Update Posted : April 9, 2018
|Condition or disease||Intervention/treatment|
|Cardiac Health||Other: questionnaire|
|Study Type :||Observational|
|Actual Enrollment :||57 participants|
|Actual Study Start Date :||November 8, 2011|
|Actual Primary Completion Date :||May 18, 2017|
|Actual Study Completion Date :||May 18, 2017|
pts who have had Rb-82 PET myocardial perfusion imaging
Eligible patients will have had Rb-82 PET myocardial perfusion imaging at MSKCC, 2008 - 2011. Patients will complete one questionnaire over the phone.
Patients will complete one questionnaire over the phone. We will ask patients to describe their cardiac history since Rb-82 PET (chest pain, shortness of breath, cardiac catheterization, and heart attack). This information will be correlated to the scan results and other relevant information in the patient's medical record.
- correlate scan findings with clinical outcomes [ Time Frame: 1 year ]Patients will complete one questionnaire over the phone.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01474577
|United States, New York|
|Memorial Sloan-Kettering Cancer Center|
|New York, New York, United States, 10065|
|Principal Investigator:||Heiko Schöder, MD||Memorial Sloan Kettering Cancer Center|